MTE #25 Advancement in Noninvasive Tests for the Diagnosis of Metabolic Dysfunction-Associated Steatohepatitis (Ticketed) | AASLD

MTE #25 Advancement in Noninvasive Tests for the Diagnosis of Metabolic Dysfunction-Associated Steatohepatitis (Ticketed)

Nov 09 2025
Convention Center: Room 149, Level 1
12:45 PM - 1:30 PM
Ticketed Event

World Class Speakers

Alina M. Allen, MD
Discussion Leader

Alina M. Allen, MD

Mayo Clinic Rochester
Raj Vuppalanchi, MD, FAASLD
Discussion Leader

Raj Vuppalanchi, MD, FAASLD

Description

Presenters explore the latest developments in noninvasive tests (NITs) for diagnosing metabolic dysfunction-associated steatohepatitis (MASH). The session covers the principles, applications, and clinical integration of advanced NITs such as imaging techniques, biomarkers, and emerging tools. Experts focus on how these methods enhance diagnostic accuracy, reduce reliance on invasive liver biopsies, and improve patient care.

Journey Maps

Objectives

  • Review the latest cutting-edge, noninvasive tests (NITs) for diagnosing MASH, including imaging modalities, serum biomarkers, and novel diagnostic algorithms.
  • Explain the interpretation of results from advanced NITs for MASH diagnosis.
  • Summarize how to integrate NITs for MASH diagnosis into clinical workflows to improve patient outcomes and reduce invasive procedures.
  • Discuss new and experimental NITs for MASH diagnosis, focusing on their potential impact, limitations, and future applications in hepatology practice.